Envista
DEXIS™IS ScanFlow v.1.0.10 adds new series of guided workflows and AI enhancements to optimize the dental implant workflow.
QUAKERTOWN, PA / ACCESSWIRE / March 19, 2024 / Earlier this year, DEXIS launched its dental implant ecosystem so clinicians can manage their entire implant workflow, from diagnosis to delivery, with one integrated toolset. To enhance workflow efficiencies, DEXIS announces the release of a new intraoral scanning update, DEXIS™IS ScanFlow v.1.0.10. The update includes a new series of guided workflows, enhancements to its AI capabilities, and an integration with DEXIS Imaging Suite software version 10.
"We are excited to introduce our latest DEXIS intraoral scanning software update, aimed at boosting productivity for DEXIS software owners and implant workflows," says Brian Gooch, VP of Marketing at DEXIS. "We've made scanning fast and easy, even for more complex situations. Digital impression data is important for implant case planning, so we enable highly accurate data to be incorporated into chairside or open workflows, and easily shared with labs or colleagues."
The IS ScanFlow software update maintains high-speed scanning, user-friendly interface, precise data capture, and an open, flexible system. Early adopters have provided positive feedback, highlighting the system's ease of use and its ability to reliably capture accurate data.
Early adopters have reported positive feedback, highlighting the wide range of cases they're able to accurately capture data for:
"The DEXIS IS 3800W intraoral scanner and its predecessors have enabled me to apply digital dentistry to all my prosthetic and implant cases," says Dr. Sebastian Patzelt. "Now, with the new AI applications in DEXIS IS ScanFlow, I'm able to digitize the soft and hard tissues of the oral cavity for fixed, removable or implant cases accurately and efficiently. *"
IS ScanFlow v1.0.10 aims to maximize productivity through AI-driven tools for dentists.
The new release adds a brand-new AI Matching tool that simplifies data capture in complex situations like multiple scan bodies, full and partial edentulism.
It also includes algorithm enhancements to its Implant Scan Body AI Assist tool which automatically detects scan bodies and reduces noise in the data, corrects artifacts and enhances details - furthering the automation of precise data capture.
IS ScanFlow v 1.0.10 introduces guided dental workflows to cut manual tasks and simplify processes.
Users now have the flexibility to fill out case information before initiating scanning or after completion, thanks to the new CaseFlow Manager tool. Regardless of the chosen option, users can then move into an easy, guided workflow that automates manual processes, predicts next steps, and assists in acquiring data for the selected indication.
The brand-new Full Arch Implant workflow guides users through the data-capture workflow for a full arch case and then automatically aligns the scans in occlusion, allowing for one consolidated dataset to send to a lab or manufacturer.
IS ScanFlow v 1.0.10 also facilitates efficient lab communication by enabling users to view case progress and real-time lab status updates directly within the Patient History screen. This allows easy collaboration, reduction in delays, and timely completion of tasks.
IS ScanFlow integrates with DTX Studio™ Clinic to connect the implant workflow
"The true power of IS ScanFlow is seen when paired with the core of the DEXIS implant ecosystem-DTX Studio Clinic," says Brian Gooch, VP of Marketing at DEXIS. "Packed with smart tools and advanced algorithms, DTX Studio Clinic serves as the clinic's imaging homebase, diagnostic hub, and treatment planning navigator. It connects each step of the implant process together and now, when purchased with an intraoral scanner, comes at no extra cost.
"Implant workflow productivity can be maximized by integrating IS ScanFlow into the rest of the tools and software within the DEXIS digital ecosystem - where practices can manage an entire implant case, from diagnosis to delivery, with one integrated toolset."
To learn more about DEXIS and the latest IS ScanFlow software version, visit https://www.dexis.com.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide patients with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances how the patient is diagnosed, accelerates the workflow, and delivers simple treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
*Dr. Robert Pauley is a paid consultant for DEXIS
Contact Information
Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533
SOURCE: DEXIS
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Beyond Work Unveils Next-Generation Memory-Augmented AI Agent (MATRIX) for Enterprise Document Intelligence23.12.2024 08:00:00 CET | Press release
Matrix streamlines document processing by cutting manual labor and operational costs, using AI agents in the enterprise. LONDON, GB / ACCESSWIRE / December 23, 2024 / Today, Beyond Work, an enterprise AI company, announced the record-setting results of Matrix, a novel memory-augmented AI framework for automating business document processing. Developed in collaboration with researchers from Penn State University, Oregon State University, and Kuehne+Nagel, one of the world's largest logistics providers, Matrix addresses the complex, time-intensive task of extracting transport references from Universal Business Language (UBL) invoices.MATRIX Results Comparing the success rates of four methods (CoT, Two-agent, Reflexion, Matrix) across GPT-4o-mini and GPT-4o, with Matrix achieving the highest performance. By harnessing an iterative, memory-centric learning strategy, Matrix achieves a 30.3% improvement over chain-of-thought prompting, outperforms a standard Large Language Model agent by 35.
Brightline Interactive Successfully Delivers A Scalable Immersive Simulation To A Global Government Service Integrator, Positioning Itself As A Leading Operating System For Processing And Visualizing Complex Information In 3D Space23.12.2024 07:00:00 CET | Press release
NEW YORK, NY / ACCESSWIRE / December 23, 2024 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR)(FSE:9DR), a diversified Immersive Technology platform company providing enterprise-focused Virtual Reality ("VR"), Augmented Reality ("AR") and Spatial Computing software and services, today announced that its subsidiary company Brightline Interactive, LLC ("BLI") successfully delivered a paid for advanced immersive simulation through its cutting-edge middleware platform - SpatialCore - to a large government services integrator ("GSI"). Leveraging the power of SpatialCore's spatial computing and AI platform, BLI was able to create a sophisticated spatial simulation in record time, setting what we believe has the potential to become a new industry standard. This initial simulation project was developed with the goal of allowing the GSI to gather simulation needs from others and to then add to this build, or for further deployment, in a cost effective and scalable manner. Tyler Gates, Genera
MicroVision Increases Production Capacity to Meet Anticipated Demand19.12.2024 09:20:00 CET | Press release
REDMOND, WA / ACCESSWIRE / December 19, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced that it has increased production capacity for its MOVIA L sensor to meet anticipated demand from the industrial sector. Building on the relationship with its existing automotive Tier 1 manufacturing partner, MicroVision expects output of MOVIA L sensors for 2025 to significantly increase compared to 2024. The continued acceleration of production capacity throughout 2025 will result in a reduced average cost per sensor, while maintaining a high-quality product suitable for industrial applications. "Securing this production capacity is critical to support high-volume orders from industrial customers, so we feel good closing out the year with this commitment in hand," said Sumit Sharma, Chief Executive Officer. "We are pleased with this scaling, particularly from a cost perspective, and our Tier 1 automotive supplier, ZF, i
Brightline Interactive Enters into an Agreement with the U.S. Navy for an Immersive, AI-Driven Simulator System19.12.2024 07:00:00 CET | Press release
NEW YORK, NY / ACCESSWIRE / December 19, 2024 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR)(FSE:9DR), a diversified Immersive Technology platform company providing enterprise-focused Virtual Reality ("VR"), Augmented Reality ("AR") and Spatial Computing software and services, today announced that its subsidiary company Brightline Interactive, LLC ("BLI") has entered into an initial six figure dollar contract with the U.S. Navy for an Immersive Simulator, to be delivered in the first half of 2025. Tyler Gates, General Manager of BLI and Chief Futurist of Glimpse, commented: "Powered by BLI's cutting-edge spatial computing platform ("SpatialCore"), we have created a game-changing technology that pushes the boundaries of what's possible via the integration of AI and Spatial Computing. The Immersive Simulator system seamlessly integrates AI into both the full motion simulation and the spatial computing environments in which they operate, offering unparalleled realism, responsiveness,
BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP19.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 19, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the expansion of its intellectual property portfolio with the filing of new international patents for sublingual delivery technologies targeting autoimmune neurodegenerative diseases. Building upon the positive International Preliminary Report on Patentability (IPRP) issued by the European Patent Office (EPO) in September 2024, BioNxt has initiated national-level filings in key jurisdictions, including the United States, Canada, Europe, and Japan. These patents are designed to protect the Company's proprietary sublingual formulations of anticancer drugs repurposed for the treatment of conditions such as Multiple Sclerosis (MS). "Securing robust intellectual property rights across major markets is a critical component of our strategy to bring innovative, patien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom